Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/02/25 | 8-A12B | Registration of securities [Section 12(b)] |
|
2 | |
| 12/02/25 | CERT | Certification by an exchange approving securities for listing |
|
1 | |
| 12/02/25 | 25-NSE | Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
|
2 | |
| 12/02/25 | 8-K | Current report |
|
  |
5 |
| 11/19/25 | 425 | Prospectuses and communications, business combinations |
|
2 | |
| 11/19/25 | 425 | Prospectuses and communications, business combinations |
|
1 | |
| 11/18/25 | 425 | Prospectuses and communications, business combinations |
|
1 | |
| 11/18/25 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 | |
| 11/18/25 | 425 | Prospectuses and communications, business combinations |
|
5 | |
| 11/18/25 | 8-K | Current report |
|
|
5 |
